TAAR1 and schizophrenia: These results are consistent with pre-clinical findings indicating the potential for antipsychotic activity associated with ulotaront7, and suggest that the mechanism of action of ulotaront, involving TAAR1 agonism, represents a potentially effective approach to the treatment of patients with schizophrenia.